The potential for growth is enormous here with the added incentive of Roche involvement

Osmetech wins $700,000 sales deal in China
By Marianne Brun-Rovet
Published: April 29 2003 12:07 | Last Updated: April 29 2003 12:07


Osmetech, the manufacturer of "electronic nose" sensors for healthcare applications, has secured a sales deal with China to assess Sars patients.


The deal, worth an initial $700,000, will use Osmetech's OPTI blood gas analysers to aid in the monitoring of Sars, which has so far infected more than 2,000 people in China.

James White, chief executive, said the deal with China was "a bit of a moving feast" as the government increased orders by the day. "There has been some interest from other governments in the region but there is much uncertainty."

The OPTI analysers are portable instruments incorporating optical sensors for blood gas, electrolyte and metabolite analysis. One of the instruments can be used for measuring the oxygen saturation and acid-base balance in Sars patients. Osmetech said this would be particularly useful in cases where treatment required the use of a ventilator of supplemental oxygen therapy.

The instrument can also be used to detect blood gas variations that frequently occur in Sars patients, but Osmetech said it was not a diagnostic tool. Osmetech acquired Roche's Atlanta-based OPTI product line of blood gas analysers in a deal worth $3.5m three weeks ago.
Tris

Tris !!

have you been on your hols ?

what about the American move, got to be good (post 42)

Hi loafy. Dont post here much these daysI remain very optimistic for OMH long term, as you know the MMs manipulate this one of late. Our frustrations should soon be over
pushing its way towards profitability. The orders received this month are already 10 times higher than the last financial year.

Guess we need to see those results pdq..beware tho loafy the MMs will have there pound of flesh given the chance!long term no problemo :0)
Tris